217 related articles for article (PubMed ID: 33996827)
1. WNT Ligand Dependencies in Pancreatic Cancer.
Aguilera KY; Dawson DW
Front Cell Dev Biol; 2021; 9():671022. PubMed ID: 33996827
[TBL] [Abstract][Full Text] [Related]
2. WNT7B mediates autocrine Wnt/β-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma.
Arensman MD; Kovochich AN; Kulikauskas RM; Lay AR; Yang PT; Li X; Donahue T; Major MB; Moon RT; Chien AJ; Dawson DW
Oncogene; 2014 Feb; 33(7):899-908. PubMed ID: 23416978
[TBL] [Abstract][Full Text] [Related]
3. Deficient Rnf43 potentiates hyperactive Kras-mediated pancreatic preneoplasia initiation and malignant transformation.
Zhou X; Sun Z; Zhang M; Qu X; Yang S; Wang L; Jing Y; Li L; Deng W; Liu F; Di J; Chen J; Wu J; Zhang H
Animal Model Exp Med; 2022 Feb; 5(1):61-71. PubMed ID: 35229994
[TBL] [Abstract][Full Text] [Related]
4. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203
[TBL] [Abstract][Full Text] [Related]
5. Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand-Addicted Pancreatic Cancer.
Aguilera KY; Le T; Riahi R; Lay AR; Hinz S; Saadat EA; Vashisht AA; Wohlschlegel J; Donahue TR; Radu CG; Dawson DW
Mol Cancer Ther; 2022 Jun; 21(6):936-947. PubMed ID: 35313331
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin ligase RNF43 downregulation increases membrane expression of frizzled receptor in pancreatic ductal adenocarcinoma.
Wang D; Tan J; Xu Y; Han M; Tu Y; Zhu Z; Dou C; Xin J; Tan X; Zeng JP; Zhao G; Liu Z
Tumour Biol; 2016 Jan; 37(1):627-31. PubMed ID: 26240024
[TBL] [Abstract][Full Text] [Related]
7. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors.
Steinhart Z; Pavlovic Z; Chandrashekhar M; Hart T; Wang X; Zhang X; Robitaille M; Brown KR; Jaksani S; Overmeer R; Boj SF; Adams J; Pan J; Clevers H; Sidhu S; Moffat J; Angers S
Nat Med; 2017 Jan; 23(1):60-68. PubMed ID: 27869803
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia Promotes Pancreatic Cancer Initiation and Progression by Activating the Wnt/β-Catenin Signaling Pathway.
Chen H; Zhao J; Jiang N; Wang Z; Liu C
Anticancer Agents Med Chem; 2021; 21(18):2592-2602. PubMed ID: 33563184
[TBL] [Abstract][Full Text] [Related]
10. Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer.
Arensman MD; Nguyen P; Kershaw KM; Lay AR; Ostertag-Hill CA; Sherman MH; Downes M; Liddle C; Evans RM; Dawson DW
Mol Cancer Res; 2015 Nov; 13(11):1509-19. PubMed ID: 26224368
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Cholesterol Metabolism and Wnt/β-Catenin Signaling Coalesce via Frizzled5 in Supporting Cancer Growth.
Zheng S; Lin J; Pang Z; Zhang H; Wang Y; Ma L; Zhang H; Zhang X; Chen M; Zhang X; Zhao C; Qi J; Cao L; Wang M; He X; Sheng R
Adv Sci (Weinh); 2022 Oct; 9(28):e2200750. PubMed ID: 35975457
[TBL] [Abstract][Full Text] [Related]
12. FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling.
Ling J; Wang F; Liu C; Dong X; Xue Y; Jia X; Song W; Li Q
J Exp Clin Cancer Res; 2019 Apr; 38(1):179. PubMed ID: 31027497
[TBL] [Abstract][Full Text] [Related]
13. Activated wnt signaling in stroma contributes to development of pancreatic mucinous cystic neoplasms.
Sano M; Driscoll DR; De Jesus-Monge WE; Klimstra DS; Lewis BC
Gastroenterology; 2014 Jan; 146(1):257-67. PubMed ID: 24067880
[TBL] [Abstract][Full Text] [Related]
14. Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer.
Hao HX; Jiang X; Cong F
Cancers (Basel); 2016 Jun; 8(6):. PubMed ID: 27338477
[TBL] [Abstract][Full Text] [Related]
15. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
Zhang Z; Xu Y
Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
[TBL] [Abstract][Full Text] [Related]
16. Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.
Sano M; Driscoll DR; DeJesus-Monge WE; Quattrochi B; Appleman VA; Ou J; Zhu LJ; Yoshida N; Yamazaki S; Takayama T; Sugitani M; Nemoto N; Klimstra DS; Lewis BC
Neoplasia; 2016 Dec; 18(12):785-794. PubMed ID: 27889647
[TBL] [Abstract][Full Text] [Related]
17. RNF43 R117fs mutant positively regulates Wnt/β-catenin signaling by failing to internalize FZD expressed on the cell surface.
Cho AR; Sul HJ; Kim YJ; Kim B; Zang DY
Sci Rep; 2022 Apr; 12(1):7013. PubMed ID: 35487932
[TBL] [Abstract][Full Text] [Related]
18. HMGN5 promotes proliferation and invasion via the activation of Wnt/β-catenin signaling pathway in pancreatic ductal adenocarcinoma.
Zhao J; Wang Y; Wu X
Oncol Lett; 2018 Sep; 16(3):4013-4019. PubMed ID: 30128022
[TBL] [Abstract][Full Text] [Related]
19. PORCN inhibition synergizes with PI3K/mTOR inhibition in Wnt-addicted cancers.
Zhong Z; Sepramaniam S; Chew XH; Wood K; Lee MA; Madan B; Virshup DM
Oncogene; 2019 Oct; 38(40):6662-6677. PubMed ID: 31391551
[TBL] [Abstract][Full Text] [Related]
20. Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma.
Raineri F; Bourgoin-Voillard S; Cossutta M; Habert D; Ponzo M; Houppe C; Vallée B; Boniotto M; Chalabi-Dchar M; Bouvet P; Couvelard A; Cros J; Debesset A; Cohen JL; Courty J; Cascone I
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
